Viridian Therapeutics
VRDN
VRDN
26 hedge funds and large institutions have $109M invested in Viridian Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 11 closing their positions.
Holders
26
Holders Change
-7
Holders Change %
-21.21%
% of All Funds
0.45%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
4
Increased
10
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PA
1
Perceptive Advisors
New York
|
$14.5M |
2 |
2
D.E. Shaw & Co
New York
|
$13.2M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$6.48M |
4 |
ABG
4
Ally Bridge Group
New York
|
$15.7M |
5 |
5
Millennium Management
New York
|
$2.15M |